Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial
1. To determine the frequency of second primary cancers commonly developing among patients initially diagnosed with lung cancer.
2. To determine the factors associated with a higher risk of second primary malignancy development.
Dr. Omar Abdel-Rahman
Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO Trial.
Expert Rev Respir Med. 2019 Aug 15 PUBMED
Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.
World J Surg. 2019 Jul 22 PUBMED